Xiangpeng Bio: A Comprehensive Anti-Aging Solution Integrating Internal and External Approaches

With the advancement of science and technology, research on “human aging” has begun to emerge. The scientific rigor and technological barriers associated with anti-aging interventions—such as collagen, hyaluronic acid, tea polyphenols, coenzyme I, and mesenchymal stem cells—are continuously increasing. “Scientific anti-aging” has become a shared pursuit in both scientific research and the market.

Xiangpeng Biotech focuses on the field of biotechnology-based anti-aging. By leveraging advanced bioscience technologies and robust medical health resources, and driven by the dual engines of top-tier medicine and biological sciences, it has developed comprehensive anti-aging solutions that address both internal and external aspects for holistic rejuvenation.

·Leveraging "supramolecular technology," which has been recognized with two Nobel Prizes, we have developed Qinghuazhi, the world's first supramolecular hyaluronic acid approved for market launch by the NMPA.^®(Registration No.: Liao G Zhuang Wang Bei Zi 2023000079).

· "Increase the transdermal molecular weight of hyaluronic acid by 200 times without damaging the skin, achieving non-invasive transdermal delivery with a molecular weight of 100,000."

· The moisturizing effect is twice that of ordinary hyaluronic acid products, and continuous use can exponentially enhance the moisturizing efficacy.

· The Enaidi Cellular Energy Replenishment Set is a functional food (health and nutritional supplement) kit, composed of the energy substance coenzyme I (NAD+) supplement and other essential life factors.

· Exclusive patented technology and formula, scientifically blended to revitalize the body and rich in multiple age-defying ingredients.

Scan the QR code on the poster to add our assistant and reserve your spot for the live stream!

He Peng | Founder of Xiangpeng Bio

Ph.D. in Basic Medicine from Peking University; Member of the Chinese Anti-Cancer Association; Member of the Chinese Society of Clinical Oncology (CSCO); Director of the Nobel Prize Medicine Summit, among other roles. With years of dedicated expertise in the field of age-reversal and anti-aging, he is committed to leveraging advanced life science technologies and high-quality medical service resources to provide comprehensive age-reversal and anti-aging solutions. He has published multiple SCI-indexed papers as the first or corresponding author and holds 100 authorized patents.Multiple items.

Xiangpeng (Beijing) Biotechnology Co., Ltd. was established in 2022 by Dr. He Peng, who holds a Medical Doctorate from Peking University. The company focuses on the field of biotechnological anti-aging, leveraging advanced biological sciences and robust medical health resources. Through a dual-drive approach combining top-tier medicine and biological science, it provides customers with comprehensive anti-aging solutions that address both internal and external aspects, thereby safeguarding human beauty, youth, and health. The company has obtained dozens of patents authorized by the China National Intellectual Property Administration. Upholding the philosophy of holistic anti-aging that integrates internal wellness with external care, the company has successively established multiple anti-aging technology platforms:

1. The company has successfully established a supramolecular technology platform based on Nobel Prize-winning technologies, and has developed a series of products including non-invasive transdermal supramolecular hyaluronic acid and collagen with a molecular weight of 100,000 Da, laying the foundation for exogenous anti-aging solutions.

2. The Company has collaborated with top-tier research institutes, universities, and hospitals both domestically and internationally to successfully establish an endogenous anti-aging technology platform. It has successfully developed the Enaidi Cellular Energy Source Oral Kit and a series of anti-aging products based on technologies involving stem cells, exosomes, and immune cells.

“Artery Select New Product Showcase” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is: to empower every milestone launch of medical innovation products.

Scan the QR code below to contact the assistant and schedule a live stream.

(If already added, please proactively contact the assistant.)